ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer

Disparities in mammogram screening amongst LGBTQ+ populations

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers

Barriers to global oncology clinical trial participation in sub-Saharan Africa

Social determinants and survival outcomes in early-onset colorectal cancer in the US

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy

ASCO 2025: Update on blood-based cancer assays

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testing

Ecological evaluation of climate risks for cancer survivors

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab

CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy shows promise